Ube to close caprolactam facility in Japan

Ube Industries says it will cease production of caprolactam at Sakai, Japan, by March 2014. Growth in demand for caprolactam has weakened with the economic downturn, and Ube’s market share has been heavily eroded by the entry of new manufacturers and expansion by existing manufacturers, mainly in China, the company says. Prices of benzene feedstock and auxiliary materials have risen too. Ube will also cease production of caprolactam derivatives at Sakai. Plants to be dismantled at the site have capacity for 100,000 m.t./year of caprolactam; 200,000 m.t./year of...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers